Evaluation of Syndecan-1 as a Novel Biomarker for Adverse Pregnancy Outcomes

[1]  M. Hod,et al.  The first-trimester of pregnancy - A window of opportunity for prediction and prevention of pregnancy complications and future life. , 2018, Diabetes research and clinical practice.

[2]  ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy. , 2018, Obstetrics and gynecology.

[3]  W. H. Pearse,et al.  American College of Obstetricians and Gynecologists , 2018, Definitions.

[4]  A. V. van Heijst,et al.  Early-onset preeclampsia is associated with perinatal mortality and severe neonatal morbidity , 2017, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[5]  D. Wright,et al.  Multicenter screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations , 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[6]  A. Althouse,et al.  Low Soluble Syndecan-1 Precedes Preeclampsia , 2016, PloS one.

[7]  D. Wright,et al.  Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation. , 2016, American journal of obstetrics and gynecology.

[8]  E. Su.  Role of the fetoplacental endothelium in fetal growth restriction with abnormal umbilical artery Doppler velocimetry. , 2015, American journal of obstetrics and gynecology.

[9]  C. Wade,et al.  Endothelial glycocalyx shedding and vascular permeability in severely injured trauma patients , 2015, Journal of Translational Medicine.

[10]  A. Shennan,et al.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. , 2015, Obstetrics and gynecology.

[11]  M. Sullivan,et al.  Placental syndecan-1 and sulphated glycosaminoglycans are decreased in preeclampsia , 2014, Journal of perinatal medicine.

[12]  S. Kane,et al.  First Trimester Biomarkers in the Prediction of Later Pregnancy Complications , 2014, BioMed research international.

[13]  S. Crawford,et al.  Gestational angiogenic biomarker patterns in high risk preeclampsia groups. , 2013, American journal of obstetrics and gynecology.

[14]  I. Kovalszky,et al.  Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome , 2013, Virchows Archiv.

[15]  P. Conzen,et al.  Increased Serum Concentrations of Circulating Glycocalyx Components in HELLP Syndrome Compared to Healthy Pregnancy: An Observational Study , 2013, Reproductive Sciences.

[16]  I. Han,et al.  Syndecans play dual roles as cell adhesion receptors and docking receptors , 2012, FEBS letters.

[17]  James M. Roberts,et al.  The placenta in preeclampsia. , 2012, Pregnancy hypertension.

[18]  L. Kiesel,et al.  Evaluation of placental syndecan‐1 expression in early pregnancy as a predictive fetal factor for pregnancy outcome , 2012, Prenatal diagnosis.

[19]  S. Brennecke,et al.  Placental syndecan expression is altered in human idiopathic fetal growth restriction. , 2012, The American journal of pathology.

[20]  L. Rasmussen,et al.  A High Admission Syndecan-1 Level, A Marker of Endothelial Glycocalyx Degradation, Is Associated With Inflammation, Protein C Depletion, Fibrinolysis, and Increased Mortality in Trauma Patients , 2011, Annals of surgery.

[21]  I. Sargent,et al.  The functions of microparticles in pre-eclampsia. , 2011, Seminars in thrombosis and hemostasis.

[22]  E. Main.  Maternal mortality: new strategies for measurement and prevention. , 2010, Current opinion in obstetrics & gynecology.

[23]  M. Götte,et al.  Syndecan-1 knock-down in decidualized human endometrial stromal cells leads to significant changes in cytokine and angiogenic factor expression patterns , 2010, Reproductive biology and endocrinology : RB&E.

[24]  K. Nicolaides,et al.  Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP‐A at 11–13 weeks , 2010, Prenatal diagnosis.

[25]  Viktoriya D. Nikolova,et al.  Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression. , 2009, Carcinogenesis.

[26]  F. Malone,et al.  Quad Screen as a Predictor of Adverse Pregnancy Outcome , 2005, Obstetrics and gynecology.

[27]  G. Dekker,et al.  Pre-eclampsia , 2005, The Lancet.

[28]  K. Lim,et al.  Circulating angiogenic factors and the risk of preeclampsia. , 2004, The New England journal of medicine.

[29]  J. Couchman.  Syndecans: proteoglycan regulators of cell-surface microdomains? , 2003, Nature Reviews Molecular Cell Biology.

[30]  B. Huppertz,et al.  Endovascular Trophoblast Invasion: Implications for the Pathogenesis of Intrauterine Growth Retardation and Preeclampsia , 2003, Biology of reproduction.

[31]  M. Götte.  Syndecans in inflammation , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  E. Ekholm,et al.  Placental expression of syndecan 1 is diminished in preeclampsia. , 2000, American journal of obstetrics and gynecology.

[33]  James J. Walker,et al.  Pre-eclampsia , 2000, The Lancet.

[34]  F. Lyall,et al.  Human trophoblast invasion and spiral artery transformation: the role of PECAM-1 in normal pregnancy, preeclampsia, and fetal growth restriction. , 1999, The American journal of pathology.

[35]  E. Ekholm,et al.  Expression of syndecan-1 in human placenta and decidua. , 1997, Placenta.

[36]  Low-Dose Aspirin Use During Pregnancy , 2018 .

[37]  D. Wright,et al.  Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. , 2016, American journal of obstetrics and gynecology.

[38]  B. Funke,et al.  Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalix. , 2011, The Journal of surgical research.

[39]  Xie Xian-yong.  Expression of Syndecan-1 in human colorectal cancer and the correlation with the clinicopathologic characteristice. , 2010 .

[40]  J. Couchman,et al.  Syndecans in wound healing, inflammation and vascular biology. , 2007, The international journal of biochemistry & cell biology.